tiprankstipranks
Trending News
More News >

John Bradley Holcomb Insider Profile

4 Followers
John Bradley Holcomb, Director at MiNK Therapeutics, holds 1.13K shares in MiNK Therapeutics (Ticker: INKT).
tipranks
John Bradley Holcomb

John Bradley Holcomb
MiNK Therapeutics (INKT)
Director

Not Ranked
John Bradley Holcomb has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11K
100.00%
A breakdown of John Bradley Holcomb's holdings

Insider Roles

MiNK Therapeutics
(INKT)
Director
Roles that John Bradley Holcomb holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by John Bradley Holcomb

John Bradley Holcomb's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MiNK Therapeutics
Dec 03, 2025
Director
Uninformative Buy
12.51K
$10.67K
John Bradley Holcomb has not reported any informative transactions for INKT, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 03, 2025
Uninformative Buy
$12.51K
1,128
$11.09
List of latest transactions for each holding click on a transaction to see John Bradley Holcomb's performance on stock

John Bradley Holcomb insider profile FAQ

What is the percentage of profitable transactions made by John Bradley Holcomb?
The percentage of profitable transactions made by John Bradley Holcomb is ―.
    What is the average return per transaction made by John Bradley Holcomb?
    The average return per transaction made by John Bradley Holcomb is ―.
      What stocks does John Bradley Holcomb hold?
      John Bradley Holcomb holds: INKT stocks.
        What was John Bradley Holcomb’s latest transaction?
        John Bradley Holcomb latest transaction was an Uninformative Buy of $12.51K.
          What was John Bradley Holcomb's most profitable transaction?
          John Bradley Holcomb’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is John Bradley Holcomb's role in MiNK Therapeutics?
            John Bradley Holcomb's role in MiNK Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.